Microbiology and Biotechnology Letters (한국미생물·생명공학회지)

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지

Gene Delivery using a Novel Cationic Liposome with Low Toxicity

저독성의 새로운 양이온성 리포좀을 이용한 유전자의 전달

  • Kang, Hyun-Gu (Department of Microbiology, Kyungpook National University) ;
  • Doh, Kyung-Oh (Department of Physiology, College of Medicine, Dongguk University) ;
  • Seu, Young-Bae (Department of Microbiology, Kyungpook National University)
  • 강현구 (경북대학교 미생물학과) ;
  • 도경오 (동국대학교 의과대학 생리학교실) ;
  • 서영배 (경북대학교 미생물학과)
  • Published : 2006.12.28
Download PDF
⟨ Previous Next ⟩

Abstract

Cationic liposome has been studied as one of the most promising non-viral gene delivery systems. In this report, we describe a new synthesized cholesterolic cationic lipid (2-aminoethylcarbamate-cholesterol) and dioleylphosphatidylethanolamine (DOPE) improve the cellular uptake properties of antisense ODNs, as well as plasmid DNA with low toxicity. This formulation of cholesterolic cationic lipid termed Chol-E, efficiently transfects ODNs and plasmids into many cell types in the presense or absence of 10% serum in the medium.

콜레스테롤 유래의 양이온성 리피드 2-aminoethylcarbamate-cholesterol(Chol-E)를 합성하여 이의 리포좀을 제조하였다. 리포좀은 다양한 비율로 중성지방인 DOPE와 섞어서 만든 후 $100{\sim}200nm$의 membrane으로 extrusion시켜 균일한 리포좀을 제작하여 크기 및 전위를 측정하였다. 형광단백질 및 luciferase plasmid의 발현을 여러가지 세포에서 확인한 결과 우수한 발현양상을 보였으며 혈청이 있는 조건에서도 발현이 증가임을 볼수 있었으며, 합성 ODNs의 전달도 adipocyte cell 에서도 잘 이루어지는 것을 확인할 수 있었다 임상실험에 쓰이는 저독성의 DC-chol에 비교하여도 독성이 적은 리포좀임을 알 수 있으며 혈청하에서도 안정하게 유전자를 전달할 수 있는 응용성이 기대되는 새로운 리포좀을 제조하였음을 알 수 있다.

Keywords

References

  1. Vasir, J. K. and V. Labhasetwar. 2006. Polymeric nanoparticles for gene delivery. Expert Opin. Drug Deliv. 3: 325-344 https://doi.org/10.1517/17425247.3.3.325
  2. Gilmore, I. R., S. P. Fox, A. J. Hollins, and S. Akhtar. 2006. Delivery strategies for siRNA-mediated gene silencing. Curr Drug Deliv. 3: 147-155 https://doi.org/10.2174/156720106776359159
  3. Khalil, I. A., K. Kogure, H. Akita, and H. Harashima. 2006. Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol. Rev. 58: 32-45 https://doi.org/10.1124/pr.58.1.8
  4. Fishbein, I., S. J. Stachelek, J. M. Connolly, R. L. Wilensky, I. Alferiev, and R. J. Levy. 2005. Site specific gene delivery in the cardiovascular system. J. Control. Release. 109: 37-48 https://doi.org/10.1016/j.jconrel.2005.09.031
  5. Racz. Z. and P. Hamar. 2006. Can siRNA technology provide the tools for gene therapy of the future. Curr. Med. Chem. 13: 2299-2307 https://doi.org/10.2174/092986706777935186
  6. Chon. H.S., W. Hu, and J. J. Kavanagh. 2006. Targeted therapies in gynecologic cancers. Curr. Cancer Drug. Targets. 6: 333-363 https://doi.org/10.2174/156800906777441799
  7. Louise. C. 2006. Nonviral vectors. Methods Mol. Biol. 333: 201-226
  8. Zhang. X. and W. T. Godbey. 2006. Viral vectors for gene delivery in tissue engineering. Adv. Dru.g Deliv. Rev. 2006 58: 515-534 https://doi.org/10.1016/j.addr.2006.03.006
  9. Mastrobattista, E., M. A. van der Aa, W. E. Hennink, and D. J. Crommelin. 2006. Artificial viruses: a nanotechnological approach to gene delivery. Nat. Rev. Dugr. Discov. 5: 115-121 https://doi.org/10.1038/nrd1960
  10. Simoes. S., A. Filipe, H. Faneca, M. Mano, N. Penacho, N. Duzgunes, and M. P. de Lima. 2005. Cationic liposomes for gene delivery. Expert. Opin. Drug. Deliv. 2: 237-254 https://doi.org/10.1517/17425247.2.2.237
  11. Konopka. K., N. Overlid, A. C. Nagaraj, and N. Duzgunes. 2006. Serum decreases the size of Metafectene-and Genejammer-DNA complexes but does not affect significantly their transfection activity in SCCVII murine squamous cell carcinoma cells. Cell. Mol. Biol. Lett. 11: 171-190 https://doi.org/10.2478/s11658-006-0015-5
  12. Lindner. L. H., R. Brock, D. Arndt-Jovin, and H. Eibl. 2006. Structural variation of cationic lipids: minimum requirement for improved oligonucleotide delivery into cells. J. Control. Release. 10: 444-456